首页> 外文期刊>Current Opinion in Cell Biology >Novel insights into G protein and G protein-coupled receptor signaling in cancer. [Review]
【24h】

Novel insights into G protein and G protein-coupled receptor signaling in cancer. [Review]

机译:对癌症中G蛋白和G蛋白偶联受体信号传导的新颖见解。 [评论]

获取原文
获取原文并翻译 | 示例
           

摘要

G protein-coupled receptors (GPCRs) play a central role in signal transmission, thereby controlling many facets of cellular function. Overwhelming evidence now implicates GPCRs, G proteins and their downstream signaling targets in cancer initiation and progression, where they can influence aberrant cell growth and survival, largely through activation of AKT/mTOR, MAPKs, and Hippo signaling pathways. GPCRs also play critical roles in the invasion and metastasis of cancer cells via activation of Rho GTPases and cytoskeletal changes, and angiogenesis to supply the tumor with nutrients and provide routes for metastasis. Lastly, GPCRs contribute to the establishment and maintenance of a permissive tumor microenvironment. Understanding GPCR involvement in cancer malignancy may help identify novel therapeutic opportunities for cancer prevention and treatment.
机译:G蛋白偶联受体(GPCR)在信号传递中起着核心作用,从而控制细胞功能的许多方面。现在有大量证据表明,GPCR,G蛋白及其下游信号转导靶点与癌症的发生和发展有关,在很大程度上它们可通过激活AKT / mTOR,MAPK和Hippo信号通路来影响异常细胞的生长和存活。 GPCR通过激活Rho GTPases和细胞骨架变化,以及通过血管生成为肿瘤提供营养并提供转移途径,在癌细胞的侵袭和转移中也起着关键作用。最后,GPCRs有助于建立和维持宽松的肿瘤微环境。了解GPCR在癌症恶性肿瘤中的参与可能有助于确定新的癌症预防和治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号